Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMT2 | O60551 | 2/20 | 0.36 |
| ▸ | NMT1 | P30419 | 2/20 | 0.36 |
| ▸ | NPY4R | P50391 | 7/20 | 0.36 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.36 |
| ▸ | NPY1R | P25929 | 5/20 | 0.36 |
| ▸ | NPY2R | P49146 | 2/20 | 0.36 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.35 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.35 |
| ▸ | TLR2 | O60603 | 1/20 | 0.34 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.33 |
| ▸ | FURIN | P09958 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13950273 | 0.92 | NPY4R (0.35) | NPY4RNPY5RNPY1RNPY2RKMT2A | |
| SCHEMBL16659354 | 0.88 | NPY4R (0.33) | NPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL27846680 | 0.79 | NPY4R (0.42) | NPY4RNPY5RNPY1RNPY2R | |
| SCHEMBL16263595 | 0.76 | NPY4R (0.48) | NMT2NMT1NPY4RNPY5RNPY1R | |
| SCHEMBL8737919 | 0.74 | L3MBTL1 (0.31) | — | |
| SCHEMBL4314216 | 0.74 | SIRT6 (0.52) | NPY4RNPY5RNPY1RNPY2RSIRT6 | |
| SCHEMBL8733027 | 0.74 | GNAI3 (0.39) | NMT2NMT1NPY4RNPY5RNPY1R | |
| SCHEMBL3421647 | 0.74 | GNAI3 (0.41) | NPY4RNPY5RNPY1RNPY2RSIRT6 | |
| SCHEMBL27554606 | 0.72 | CAD (0.39) | NPY4RNPY5RNPY1RNPY2RKMT2A | |
| SCHEMBL8019370 | 0.72 | CAD (0.39) | NPY4RNPY5RNPY1RNPY2RKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150111812-A1 | POLYSACCHARIDE-BASED HYDROGELS AND HYBRID HYDROGELS AND PRECURSORS THEREOF, METHODS OF MAKING SAME, AND USES THEREOF | CORNELL UNIVERSITY | 2015-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150111812-A1 | POLYSACCHARIDE-BASED HYDROGELS AND HYBRID HYDROGELS AND PRECURSORS THEREOF, METHODS OF MAKING SAME, AND USES THEREOF | CD44, CHIA, ARG1 | NMT2 810/4885NMT1 701/4885NPY4R 791/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.